MAYO CLINIC
πΊπΈUnited States
- Country
- πΊπΈUnited States
- Ownership
- Subsidiary
- Established
- 1889-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mayoclinic.org
The Impact of Integrative Medicine on Patient-Reported Outcomes in Management of Chronic Pelvic Pain
Not Applicable
Completed
- Conditions
- Chronic Female Pelvic Pain Syndrome (Disorder)
- Interventions
- Behavioral: Mindfulness counseling
- First Posted Date
- 2021-02-26
- Last Posted Date
- 2021-11-05
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 15
- Registration Number
- NCT04773925
- Locations
- πΊπΈ
Mayo Clinic in Florida, Jacksonville, Florida, United States
Community-Engaged Bidirectional Pandemic Crisis and Emergency Risk Communication With COVID-19 Vaccine Messages to Minority Populations
Not Applicable
Completed
- Conditions
- Vaccine Preventable Disease
- Interventions
- Other: Educational, culturally appropriate COVID-19 messages
- First Posted Date
- 2021-02-23
- Last Posted Date
- 2021-07-30
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 74
- Registration Number
- NCT04765839
- Locations
- πΊπΈ
Mayo Clinic, Rochester, Minnesota, United States
A Study to Evaluate Effects of Gargle Phonation in Voice
Not Applicable
Completed
- Conditions
- Voice DisordersMuscle Tension DysphoniaSpeech Therapy
- Interventions
- Other: Water swallowOther: Gargle Phonation
- First Posted Date
- 2021-02-23
- Last Posted Date
- 2022-10-19
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 36
- Registration Number
- NCT04766658
- Locations
- πΊπΈ
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
πΊπΈMayo Clinic in Rochester, Rochester, Minnesota, United States
Selinexor, Pomalidomide, and Dexamethasone With or Without Carfilzomib for the Treatment of Patients With Relapsed Refractory Multiple Myeloma, The SCOPE Trial
Phase 1
Recruiting
- Conditions
- Recurrent Multiple MyelomaRefractory Multiple Myeloma
- Interventions
- Drug: CarfilzomibDrug: DexamethasoneOther: Quality-of-Life AssessmentDrug: PomalidomideOther: Questionnaire AdministrationDrug: SelinexorProcedure: X-Ray ImagingProcedure: Computed TomographyProcedure: Positron Emission TomographyProcedure: Bone Marrow BiopsyProcedure: Bone Marrow AspirationProcedure: Biospecimen Collection
- First Posted Date
- 2021-02-21
- Last Posted Date
- 2024-01-17
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 81
- Registration Number
- NCT04764942
- Locations
- πΊπΈ
Mayo Clinic in Rochester, Rochester, Minnesota, United States
68Ga-PSMA-Dual-Contrast PET/MRI or PET/CT for Early Detection of Liver Cancer
Phase 2
Recruiting
- Conditions
- Hepatocellular Carcinoma
- Interventions
- Procedure: Computed TomographyDrug: Gallium Ga 68 GozetotideProcedure: Magnetic Resonance ImagingProcedure: Positron Emission Tomography
- First Posted Date
- 2021-02-21
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 52
- Registration Number
- NCT04762888
- Locations
- πΊπΈ
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Determining Molecular Drivers of Radiation Dermatitis
Active, not recruiting
- Conditions
- Breast Cancer
- First Posted Date
- 2021-02-21
- Last Posted Date
- 2024-04-11
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 20
- Registration Number
- NCT04764682
- Locations
- πΊπΈ
Mayo Clinic, Jacksonville, Florida, United States
PET Imaging to Delineate Macrophage Activation in Diabetic Gastroparesis
Phase 2
Completed
- Conditions
- Gastroparesis With Diabetes MellitusDiabetes
- Interventions
- Drug: PET/CT Scan with 11C-ER176Diagnostic Test: Core biopsy of gastric muscle
- First Posted Date
- 2021-02-21
- Last Posted Date
- 2023-04-18
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 12
- Registration Number
- NCT04762719
- Locations
- πΊπΈ
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Provider Perspectives on Beta-lactam Therapeutic Drug Monitoring Programs in the Critically Ill
Completed
- Conditions
- Critical IllnessSepsis
- First Posted Date
- 2021-02-16
- Last Posted Date
- 2023-02-21
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 138
- Registration Number
- NCT04755777
- Locations
- πΊπΈ
UF Health Shands, Gainesville, Florida, United States
πΊπΈMayo Clinic, Rochester, Minnesota, United States
π¦πΊRoyal Brisbane and Women's Hospital, Herston, Queensland, Australia
CGM Use in COVID19 Patients (Infection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2))
Not Applicable
Completed
- Conditions
- Diabetes MellitusCovid19
- Interventions
- Device: Continuous Glucose Monitor (CGM)
- First Posted Date
- 2021-02-16
- Last Posted Date
- 2023-08-04
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 20
- Registration Number
- NCT04756141
- Locations
- πΊπΈ
Mayo Clinic in Florida, Jacksonville, Florida, United States
Prospective Sinonasal Cancer Multi-institution Study
Recruiting
- Conditions
- Sinonasal Carcinoma
- First Posted Date
- 2021-02-16
- Last Posted Date
- 2024-08-16
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 200
- Registration Number
- NCT04755855
- Locations
- πΊπΈ
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Β© Copyright 2025. All Rights Reserved by MedPath